RTTNews | Dec 16, 2021 10:02AM EST

10:01 Thursday, December 16, 2021 (RTTNews) - AstraZeneca's EVUSHELD Retains Neutralizing Activity Against Omicron SARS-CoV-2 Variant : New Preclinical Data

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved